Hologic Statistics
Total Valuation
Hologic has a market cap or net worth of $18.32 billion. The enterprise value is $18.50 billion.
| Market Cap | 18.32B |
| Enterprise Value | 18.50B |
Important Dates
The last earnings date was Monday, November 4, 2024, after market close.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Hologic has 232.27 million shares outstanding. The number of shares has decreased by -3.93% in one year.
| Current Share Class | 232.27M |
| Shares Outstanding | 232.27M |
| Shares Change (YoY) | -3.93% |
| Shares Change (QoQ) | -0.21% |
| Owned by Insiders (%) | 1.38% |
| Owned by Institutions (%) | 103.42% |
| Float | 228.83M |
Valuation Ratios
The trailing PE ratio is 26.95 and the forward PE ratio is 18.40. Hologic's PEG ratio is 1.78.
| PE Ratio | 26.95 |
| Forward PE | 18.40 |
| PS Ratio | 4.67 |
| Forward PS | 4.21 |
| PB Ratio | 3.66 |
| P/TBV Ratio | 18.64 |
| P/FCF Ratio | 17.69 |
| P/OCF Ratio | 15.40 |
| PEG Ratio | 1.78 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.89, with an EV/FCF ratio of 18.06.
| EV / Earnings | 26.37 |
| EV / Sales | 4.64 |
| EV / EBITDA | 14.89 |
| EV / EBIT | 19.68 |
| EV / FCF | 18.06 |
Financial Position
The company has a current ratio of 3.99, with a Debt / Equity ratio of 0.52.
| Current Ratio | 3.99 |
| Quick Ratio | 3.07 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 2.01 |
| Debt / FCF | 2.50 |
| Interest Coverage | 7.95 |
Financial Efficiency
Return on equity (ROE) is 13.85% and return on invested capital (ROIC) is 7.56%.
| Return on Equity (ROE) | 13.85% |
| Return on Assets (ROA) | 6.45% |
| Return on Capital (ROIC) | 7.56% |
| Revenue Per Employee | $570,472 |
| Profits Per Employee | $100,358 |
| Employee Count | 6,990 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.34 |
Taxes
In the past 12 months, Hologic has paid $87.60 million in taxes.
| Income Tax | 87.60M |
| Effective Tax Rate | 11.10% |
Stock Price Statistics
The stock price has increased by +9.56% in the last 52 weeks. The beta is 0.99, so Hologic's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | +9.56% |
| 50-Day Moving Average | 80.49 |
| 200-Day Moving Average | 77.61 |
| Relative Strength Index (RSI) | 45.51 |
| Average Volume (20 Days) | 1,626,989 |
Short Selling Information
The latest short interest is 4.85 million, so 2.09% of the outstanding shares have been sold short.
| Short Interest | 4.85M |
| Short Previous Month | 5.81M |
| Short % of Shares Out | 2.09% |
| Short % of Float | 2.12% |
| Short Ratio (days to cover) | 3.63 |
Income Statement
In the last 12 months, Hologic had revenue of $3.99 billion and earned $701.50 million in profits. Earnings per share was $2.92.
| Revenue | 3.99B |
| Gross Profit | 2.42B |
| Operating Income | 940.00M |
| Pretax Income | 789.10M |
| Net Income | 701.50M |
| EBITDA | 1.24B |
| EBIT | 940.00M |
| Earnings Per Share (EPS) | $2.92 |
Balance Sheet
The company has $2.45 billion in cash and $2.56 billion in debt, giving a net cash position of -$111.60 million or -$0.48 per share.
| Cash & Cash Equivalents | 2.45B |
| Total Debt | 2.56B |
| Net Cash | -111.60M |
| Net Cash Per Share | -$0.48 |
| Equity (Book Value) | 4.95B |
| Book Value Per Share | 21.33 |
| Working Capital | 2.99B |
Cash Flow
In the last 12 months, operating cash flow was $1.18 billion and capital expenditures -$152.40 million, giving a free cash flow of $1.02 billion.
| Operating Cash Flow | 1.18B |
| Capital Expenditures | -152.40M |
| Free Cash Flow | 1.02B |
| FCF Per Share | $4.41 |
Margins
Gross margin is 60.58%, with operating and profit margins of 23.57% and 17.59%.
| Gross Margin | 60.58% |
| Operating Margin | 23.57% |
| Pretax Margin | 19.79% |
| Profit Margin | 17.59% |
| EBITDA Margin | 31.16% |
| EBIT Margin | 23.57% |
| FCF Margin | 25.44% |
Dividends & Yields
Hologic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.93% |
| Shareholder Yield | 3.93% |
| Earnings Yield | 3.87% |
| FCF Yield | 5.65% |
Analyst Forecast
The average price target for Hologic is $89.91, which is 13.97% higher than the current price. The consensus rating is "Buy".
| Price Target | $89.91 |
| Price Target Difference | 13.97% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 5.01% |
| EPS Growth Forecast (5Y) | 25.16% |
Stock Splits
The last stock split was on April 3, 2008. It was a forward split with a ratio of 2:1.
| Last Split Date | Apr 3, 2008 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Hologic has an Altman Z-Score of 4.31 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.31 |
| Piotroski F-Score | 6 |